Viewing Study NCT06576102

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:55 AM
Ignite Modification Date: 2026-01-12 @ 3:50 AM
Study NCT ID: NCT06576102
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-27
First Post: 2024-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
Sponsor: Maddalena Giannella
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Persistent COVID-19 View
None B Cell Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Persistent SARS-CoV-2 infection View
None Immunocompromised patients View
None B cell malignancies View
None B cell targeting therapies View
None viral infections in the hematological patient View